Tissue Engineering Technologies in the Management of Bone Infections

Osteomyelitis is a calamitous illness produced by microbial infection in deep osseous tissue. Its elevated recurrence percentage is a major defiance in management. Besides, microbial-mediated dysregulation of the osseous tissue immune microhabitat hinders the process of osseous regeneration, resulting in defective repair of the osseous defect. In spite of advancements in surgical approaches and medication employments for the management of infections of the osseous tissue within the most recent years, dares endure in clinical treatment. The creation and employment of tissue engineering materials have rendered new approaches for the management of infections of the osseous tissue. In the discipline of tissue engineering, we should center on utilizing materials science and engineering technology to create biomimetic 3D printed degradable frameworks with structure, layout, and mechanical attributes; accomplishing controlled liberation of antimicrobial medications via nanocarriers or scaffold surface coating technologies; and utilizing coaxial printing or gradient printing techniques to accomplish graded controlled liberation of antimicrobial medications and osteogenic active drugs.